Trials / Completed
CompletedNCT01565382
Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)
Evaluation of Physician Training for Interpretation of Florbetapir-PET Scans: Evaluation of Inter-reader Reliability Using Images From Subjects With a Clinical Presentation of AD or MCI
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Re-read of brain amyloid scans acquired in previous AV-45 clinical studies by readers trained using updated reading methodology. The scans in this study came from subjects who had Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | florbetapir F 18 | IV injection, 370MBq (10mCi), single dose (intervention for Study A05 participants, source of scans for this study) |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2012-03-28
- Last updated
- 2022-08-16
- Results posted
- 2012-06-27
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01565382. Inclusion in this directory is not an endorsement.